Activated B-cell Diffuse Large B-Cell Lymphoma (ABC DLBCL)
1 clinical trials · Condition
◉ Watch Activated B-cell Diffuse Large B-Cell Lymphoma (ABC DLBCL)
| Record | Firm | Date |
|---|---|---|
| Acalabrutinib (ACP-196), a Btk Inhibitor, for Treatment of de Novo Activated B-cell (ABC) Subtype of Diffuse Large B-Cell Lymphoma (NCT02112526) | Acerta Pharma BV | 2014-08-07 |
Track Activated B-cell Diffuse Large B-Cell Lymphoma (ABC DLBCL) automatically
Every clearance here is in the API, with alerts when new ones post.